Company Filing History:
Years Active: 2020-2024
Title: Sally Margaret Hensman: Innovator in Respiratory Assistance Technologies
Introduction
Sally Margaret Hensman is a notable inventor based in Auckland, New Zealand. She has made significant contributions to the field of respiratory assistance systems, holding a total of 3 patents. Her innovative designs focus on improving the usability and efficiency of medical devices used in respiratory care.
Latest Patents
One of her latest patents is titled "Fluid flowback prevention in a wye-piece connector." This invention addresses the issue of condensate drainage into inspiratory conduits by designing connectors that strategically position the expiratory conduit below the inspiratory conduit. This configuration helps to minimize the amount of condensate that can enter the inspiratory branch, enhancing the overall functionality of respiratory systems.
Another significant patent is related to "Usability features for respiratory humidification systems." This humidification system is designed to deliver humidified gases effectively to users. It includes a heater base, a humidification chamber, and a breathing circuit that simplifies the setup process. Features such as color-coded components and intuitive structures are incorporated to reduce setup time and minimize errors, making the system more user-friendly.
Career Highlights
Sally Hensman is currently employed at Fisher & Paykel Healthcare Limited, a company renowned for its innovative healthcare solutions. Her work focuses on developing advanced technologies that improve patient care in respiratory therapy.
Collaborations
Throughout her career, Sally has collaborated with esteemed colleagues, including David Robert Kemps and Simon Mordechai Stam. These collaborations have further enhanced her contributions to the field of respiratory assistance.
Conclusion
Sally Margaret Hensman is a pioneering inventor whose work in respiratory assistance technologies has made a significant impact on patient care. Her innovative patents and commitment to improving medical devices continue to shape the future of respiratory therapy.